The 3D Bioprinter initiative of TECNALIA and the University of the Basque Country, awarded by Diario Médico and Correo Farmacéutico Diario Médico and Correo Farmacéutico have held the third edition of the Ennova Health 2023 awards, which recognize the work of professionals, institutions and companies whose digital initiatives have contributed value, contributed to the sustainability of the system and improved patient life throughout 2022/23 The 3D Bioprinters initiative of TECNALIA and the University of the Basque Country, which has already created its first drugs and biological prototypes, has won the award in the category of Digital Patient Empowerment November 21, 2023. The 3D Biompression initiative developed by the research and technological development center TECNALIA and the University of the Basque Country UPV/EHU has been recognized by Diario Médico and Correo Farmacéutico and the innovation and health awards they deliver annually, in the category of Digital Empowerment of the Patient.
This project is supported by the Provincial Council of Alava, and during this year and 2024, the researchers are focusing on the experimental phase and evolution of the software and intelligence of the machine, with the aim that hospitals